Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8VVK

CCHFV GP38 bound to ADI-46143 Fab

8VVK の概要
エントリーDOI10.2210/pdb8vvk/pdb
分子名称GP38, ADI-46143 Fab Light Chain, ADI-46143 Fab Heavy Chain, ... (6 entities in total)
機能のキーワードcchfv, gp38, antibody, immunology, viral protein, viral protein-immune system complex, viral protein/immune system
由来する生物種Crimean-Congo hemorrhagic fever virus
詳細
タンパク質・核酸の鎖数6
化学式量合計154745.98
構造登録者
Hjorth, C.K.,McLellan, J.S. (登録日: 2024-01-31, 公開日: 2024-07-17, 最終更新日: 2024-10-30)
主引用文献Shin, O.S.,Monticelli, S.R.,Hjorth, C.K.,Hornet, V.,Doyle, M.,Abelson, D.,Kuehne, A.I.,Wang, A.,Bakken, R.R.,Mishra, A.K.,Middlecamp, M.,Champney, E.,Stuart, L.,Maurer, D.P.,Li, J.,Berrigan, J.,Barajas, J.,Balinandi, S.,Lutwama, J.J.,Lobel, L.,Zeitlin, L.,Walker, L.M.,Dye, J.M.,Chandran, K.,Herbert, A.S.,Pauli, N.T.,McLellan, J.S.
Crimean-Congo hemorrhagic fever survivors elicit protective non-neutralizing antibodies that target 11 overlapping regions on glycoprotein GP38.
Cell Rep, 43:114502-114502, 2024
Cited by
PubMed Abstract: Crimean-Congo hemorrhagic fever virus can cause lethal disease in humans yet there are no approved medical countermeasures. Viral glycoprotein GP38, exclusive to Nairoviridae, is a target of protective antibodies and is a key antigen in preclinical vaccine candidates. Here, we isolate 188 GP38-specific antibodies from human survivors of infection. Competition experiments show that these antibodies bind across 5 distinct antigenic sites, encompassing 11 overlapping regions. Additionally, we show structures of GP38 bound with 9 of these antibodies targeting different antigenic sites. Although these GP38-specific antibodies are non-neutralizing, several display protective efficacy equal to or better than murine antibody 13G8 in two highly stringent rodent models of infection. Together, these data expand our understanding regarding this important viral protein and may inform the development of broadly effective CCHFV antibody therapeutics.
PubMed: 39002130
DOI: 10.1016/j.celrep.2024.114502
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.61 Å)
構造検証レポート
Validation report summary of 8vvk
検証レポート(詳細版)ダウンロードをダウンロード

252456

件を2026-04-22に公開中

PDB statisticsPDBj update infoContact PDBjnumon